IBRN ETF

IBRN ETF
$39.18
Screen 5,700+ ETFsFind similar ETFs with lower fees
See inside every fund you own
$45/quarter Pro · Cancel anytime
X-ray my whole portfolio

Returns Overview

1 Month
+8.45%
3 Months
+18.20%
6 Months
+20.40%
YTD
+22.29%
1 Year
+77.63%
3 Years (annualized)
+17.20%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IBRN have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index(NYFSNBMT)
This ETF (YTD)
+22.29%
Peer Avg (YTD)
+7.57%
vs Peers
+14.72%

IBRN ETF Performance

IBRN performance across multiple time periods: 1-month 8.45%, YTD 22.29%, 1-year 77.63%, 3-year 17.20%.

IBRN returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IBRN performance comparison shows side-by-side returns with another fund. IBRN alternatives are available in the ETF Screener.

Compare IBRN

IBRN vs SPYIBRN vs QQQIBRN vs VOOIBRN vs VTIIBRN vs IVVIBRN vs SCHDIBRN vs VYMIBRN vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+8.45%N/A
3 Months+18.20%N/A
6 Months+20.40%N/A
1 Year+77.63%N/A
3 Years+17.20%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized